We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advancing Monoclonal Cell Line Development: Technologies and Challenges

3D illustration of an antibody structure with yellow antigen-binding sites against a dark background with scattered particles
Credit: iStock

Monoclonality in cell line development is an essential requirement for bioproduction, analytics and therapeutics such as biologics and advanced therapy medicinal products (ATMPs) for applications in multi-omics, immuno-oncology, drug discovery, regenerative medicine and more. 


Traditional techniques like FACS, microfluidics and limiting dilution isolate and clone single cells. However, by isolating single-cell derived monoclonal colonies instead, researchers can enhance the precision and effectiveness of biopharmaceutical research. 


This whitepaper explores the available technologies, key challenges and the growing impact of single-cell cloning.


Download this whitepaper to learn more about:

  • The limitations of traditional methods 
  • An effective solution that can save on costs as well as improving viability 
  • How this platform can accelerate drugs to market 
Brought to you by

Download the Whitepaper for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.